Dogwood Therapeutics Inc (DWTX) has disclosed a new risk, in the Debt & Financing category. Dogwood Therapeutics Inc. faces a significant risk with the potential exercise of a Repurchase Option by ...
Good morning and welcome to the Dogwood Therapeutics Incorporated third quarter, 2024 earnings call. At this time, all participants have been placed on a listen-only mode. Please be advised that today ...